A Trial to Evaluate the Immunogenicity of Accelerated Primary Vaccination With Monovalent A/Indonesia/5/05 (H5N1) Vaccine Antigen in Association With AS03 Adjuvant in Adults Aged 18-64.
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2018
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary) ; AS03A
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 03 Feb 2009 Status changed from active, no longer recruiting to completed.
- 09 Jul 2008 New trial record.